Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
When combining both peptides for a BPC-157 TB-500 stack , each can be reconstituted separately and drawn into the same syringe, or researchers can use the pre-blended formulation which has been verified for chemical compatibility and stability
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
Potency Check Confirms active ingredient concentration stays within 10% of the prescribed formula
They do not, except at one downstream point of overlap
Peptidomimetic glutathione analogues as novel gammaGT stable GST inhibitors
GHK-Cu provides essential support through optimization of collagen quality via TGF- pathway activation and copper delivery for lysyl oxidase-mediated cross-linking that determines tissue mechanical properties
US$ 24.08
US$ 28.08
US$ 22.48
US$ 25.80
